You just read:

1ST Biotherapeutics and twoXAR Advance Three Novel Glioblastoma Treatment Candidates into In Vivo Testing in Less Than One Year

News provided by

twoXAR Pharmaceuticals

Feb 25, 2020, 09:00 ET